{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lectines liant le mannose : Questions médicales les plus fréquentes",
"headline": "Lectines liant le mannose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lectines liant le mannose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2025-03-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lectines liant le mannose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lectines",
"url": "https://questionsmedicales.fr/mesh/D037102",
"about": {
"@type": "MedicalCondition",
"name": "Lectines",
"code": {
"@type": "MedicalCode",
"code": "D037102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lectine liant le mannose",
"alternateName": "Mannose-Binding Lectin",
"url": "https://questionsmedicales.fr/mesh/D037601",
"about": {
"@type": "MedicalCondition",
"name": "Lectine liant le mannose",
"code": {
"@type": "MedicalCode",
"code": "D037601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503.311.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lectines liant le mannose",
"alternateName": "Mannose-Binding Lectins",
"code": {
"@type": "MedicalCode",
"code": "D037241",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jatinder Singh",
"url": "https://questionsmedicales.fr/author/Jatinder%20Singh",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Manpreet Kaur",
"url": "https://questionsmedicales.fr/author/Manpreet%20Kaur",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Namarta Kalia",
"url": "https://questionsmedicales.fr/author/Namarta%20Kalia",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India."
}
},
{
"@type": "Person",
"name": "Kárita Cláudia Freitas Lidani",
"url": "https://questionsmedicales.fr/author/K%C3%A1rita%20Cl%C3%A1udia%20Freitas%20Lidani",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil."
}
},
{
"@type": "Person",
"name": "Fabiana Antunes Andrade",
"url": "https://questionsmedicales.fr/author/Fabiana%20Antunes%20Andrade",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Associations between muscle morphology and spasticity in children with spastic cerebral palsy.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36706682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpn.2023.01.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37209500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104745"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rebalancing the Spastic Wrist by Transposition of Antagonistic Muscle-Tendon Complex.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/34711790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BTH.0000000000000371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methods of muscle spasticity assessment in children with cerebral palsy: a scoping review.",
"datePublished": "2024-07-11",
"url": "https://questionsmedicales.fr/article/38992701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13018-024-04894-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Focal muscle spasticity has little impact on muscle power for walking in people with Traumatic Brain Injury.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37295342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinbiomech.2023.105978"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lectines",
"item": "https://questionsmedicales.fr/mesh/D037102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lectines liant le mannose",
"item": "https://questionsmedicales.fr/mesh/D037241"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lectines liant le mannose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lectines liant le mannose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lectines liant le mannose",
"description": "Comment diagnostiquer une déficience en lectines liant le mannose ?\nQuels tests sont utilisés pour évaluer les lectines ?\nLes niveaux de lectines peuvent-ils varier ?\nQuels symptômes peuvent indiquer un problème avec les lectines ?\nPeut-on mesurer les lectines dans d'autres fluides ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lectines liant le mannose",
"description": "Quels symptômes sont associés à une déficience en lectines ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?\nLes symptômes sont-ils toujours visibles ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lectines liant le mannose",
"description": "Comment prévenir les infections chez les patients déficients ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes exercices physiques sont-ils bénéfiques ?\nY a-t-il des mesures spécifiques à prendre ?\nLes consultations médicales régulières sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lectines liant le mannose",
"description": "Quels traitements sont disponibles pour les déficiences en lectines ?\nLes suppléments peuvent-ils aider ?\nLa vaccination est-elle recommandée ?\nY a-t-il des traitements expérimentaux ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lectines liant le mannose",
"description": "Quelles complications peuvent survenir avec une déficience en lectines ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il un risque accru de cancer ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lectines liant le mannose",
"description": "Quels sont les facteurs de risque pour les déficiences en lectines ?\nL'âge influence-t-il le risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Muscle+Spasticity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en lectines liant le mannose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux de lectines et évaluer la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les lectines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'immunoessai et les dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les niveaux de lectines peuvent-ils varier ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de lectines peuvent fluctuer en fonction de l'état de santé et des infections."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec les lectines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections récurrentes ou des maladies auto-immunes peuvent signaler un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les lectines dans d'autres fluides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lectines peuvent également être mesurées dans les fluides corporels comme la salive."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une déficience en lectines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des infections fréquentes, des allergies et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment chez les enfants et les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir en raison de réactions immunitaires anormales."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques malgré une déficience en lectines."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent devenir plus graves et fréquents."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections chez les patients déficients ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, des vaccinations et un suivi médical régulier sont essentiels."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut renforcer le système immunitaire et la santé globale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques sont-ils bénéfiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé immunitaire et réduire le stress."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures spécifiques à prendre ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules et se laver les mains fréquemment sont des mesures préventives clés."
}
},
{
"@type": "Question",
"name": "Les consultations médicales régulières sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations régulières permettent de surveiller la santé et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déficiences en lectines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies immunomodulatrices et des antibiotiques préventifs."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments nutritionnels peuvent soutenir le système immunitaire, mais pas spécifiquement les lectines."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des thérapies géniques et des traitements ciblés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en lectines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections graves, des maladies auto-immunes et des allergies."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être fatales si elles ne sont pas traitées rapidement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un risque accru de cancer chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent causer des dommages permanents."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de laboratoire aident à surveiller les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déficiences en lectines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les infections fréquentes et certaines maladies génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles de présenter des déficiences."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies auto-immunes peuvent avoir un risque accru de déficiences."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, comme le tabagisme, peut augmenter le risque de déficiences immunitaires."
}
},
{
"@type": "Question",
"name": "Les infections chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques peuvent affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
Internal Medicine Post Graduate, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil; Department of Medicine, Positivo University, Curitiba, Brazil. Electronic address: renatonisihara@gmail.com.
Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Łódź, Poland. Electronic address: mcedzynski@cbm.pan.pl.
Due to the heterogeneous clinical presentation of spastic cerebral palsy (SCP), which makes spasticity treatment challenging, more insight into the complex interaction between spasticity and altered m...
We studied associations between spasticity and muscle morphology and compared muscle morphology between commonly observed spasticity patterns (i.e. different muscle activation patterns during passive ...
Spasticity and muscle morphology of the medial gastrocnemius (MG) and semitendinosus (ST) were defined in 74 children with SCP (median age 8 years 2 months, GMFCS I/II/III: 31/25/18, bilateral/unilate...
A moderate negative association (r = -0.624, p < 0.001) was found between spasticity and MG muscle volume, while other significant associations between spasticity and muscle morphology parameters were...
Higher spasticity levels were associated with smaller MG and ST volumes and shorter MG muscles. These muscle morphology alterations were more pronounced in muscles that activated during low-velocity s...
To provide a comprehensive assessment of the treatment effects of nabiximols oromucosal spray on multiple sclerosis spasticity in two clinical trials, GWSP0604 and SAVANT....
Both studies enriched for responders before randomization, defined by a ≥20% improvement in Spasticity 0-10 numeric rating scale (NRS) score. Additionally, SAVANT used randomized re-titration followin...
Mean change from baseline in average daily Spasticity NRS scores was significantly larger for nabiximols than placebo at all postbaseline timepoints, ranging from -0.36 to -0.89 in GWSP0604 and -0.52 ...
Nabiximols leads to improvement in spasticity that was sustained over the 12-week treatment period as measured by average daily Spasticity NRS scores, daily spasm counts, and MAS scores for combinatio...
Upper limb spasticity and spasticity-induced deformities after upper motor neuron lesions because of traumatic brain injury, encephalitis or cerebral palsy inhibit activities of daily living, result i...
Evaluating muscle spasticity in children with cerebral palsy (CP) is essential for determining the most effective treatment strategies. This scoping review assesses the current methods used to evaluat...
A search (to April 2024) used keywords such as muscle spasticity, cerebral palsy, and assessment methods. Selection criteria included articles involving CP children, assessing spasticity objectively/s...
From an initial pool of 1971 articles, 30 met our inclusion criteria. These studies collectively appraised a variety of techniques ranging from well-established clinical scales like the modified Ashwo...
The review discussed the strengths and limitations of each method and concluded that more reliable methods are needed to measure the level of muscle spasticity more accurately....
Spasticity is prevalent following Traumatic Brain Injury. 'Focal' muscle spasticity has been defined as spasticity affecting a localised muscle group, but it's impact on gait kinetics remains unclear....
Ninety-three participants attending physiotherapy for mobility limitations following Traumatic Brain Injury were invited to participate in the study. Participants underwent clinical gait analysis and ...
Hip extensor power generation at initial contact, hip flexor power generation at terminal stance, and knee extensor power absorption at terminal stance were all significantly increased, and ankle powe...
Focal muscle spasticity had little association with abnormal gait kinetics in this cohort of independently ambulant people with Traumatic Brain Injury....
To investigate the influence of muscle position (relaxed vs stretched) on muscle mechanical properties and the ability of myotonometry to detect differences between sides, groups, and sites of testing...
Cross-sectional study....
Outpatient rehabilitation units including private and public centers....
Seventy-one participants (20 subacute stroke, 20 chronic stroke, 31 controls) were recruited (N=71)....
Muscle mechanical properties were measured bilaterally with a MyotonPRO at muscle belly and musculotendinous sites during 2 protocols (muscle relaxed or in maximal bearable stretched position)....
Muscle tone and stiffness of the biceps brachii and gastrocnemius. Poststroke spasticity was evaluated with the Modified Tardieu Scale (MTS). A mixed-model analysis of variance was used to detect diff...
The analysis of variance showed a significant effect of muscle position on muscle mechanical properties (higher tone and stiffness with the muscle assessed in stretched position). Measurements with th...
Myotonometry assessment of mechanical properties with the muscle stretched improves the ability of myotonometry to discriminate between sides in patients after stroke and between people with and witho...
In cerebral palsy (CP), spasticity is the dominant symptom and hip pain is one of the most common secondary conditions. Aetiology is not clear. Musculoskeletal ultrasound (MSUS) is a low-cost, non-inv...
A retrospective case-matched-control study. To investigate associated factors with painful spastic hip and to compare ultrasound findings (focusing on muscle thickness) in children with CP vs. typical...
Paediatric Rehabilitation Hospital in Mexico City, from August to November 2018....
21 children (13 male, 7 + 4.26 years) with CP, in Gross Motor Function Classification System (GMFCS) levels IV to V, with spastic hip diagnosis (cases) and 21 children age- and sex-matched (7 + 4.28 y...
Sociodemographic data, CP topography, degree of spasticity, mobility arch, contractures, Visual Analog Scale (VAS), GMFCS, measurements of the volumes of eight major muscles of the hip joint and MSUS ...
All children with CP group reported chronic hip pain. Associated factors for hip pain (high VAS hip pain score) were degree of hip displacement (percentage of migration), Ashworth Level, GMFCS level V...
Though possibly the most important issue with diminished muscle growth in CP children is the influence on their long-term function, it is likely that training routines that build muscle size may also ...
Botulinum neurotoxin-A (BoNT-A) injections are effective for focal spasticity. However, the impact on muscle strength is not established. This study aimed to investigate the effect of BoNT-A injection...
Although reduced gait asymmetry and trunk control are generally accepted outcomes in stroke patients after having a stroke, the number of studies examining the factors affecting gait symmetry and trun...
What are the effects of gastrocnemius muscle spasticity on trunk control and gait symmetry in chronic stroke patients?...
The sample of the study included 29 individuals aged 40-70 who were diagnosed with stroke at least six months ago. The sociodemographic information of the patients was collected using a descriptive in...
There was a numerical difference between the gait symmetry results of the patients who had a MAS score lower than 2 and those who had a MAS score of 2 or higher, where MAS scores corresponded to gastr...
According to the results of our study, to improve trunk control and gait in stroke survivors, the management of gastrocnemius muscle spasticity should be included in rehabilitation programs. We believ...
Evaluation the effects of dry needling on sonographic, biomechanical and functional parameters of spastic upper extremity muscles....
Twenty-four patients (35-65 years) with spastic hand were randomly allocated into two equal groups: intervention and sham-controlled groups. The treatment protocol was 12-sessions neurorehabilitation ...
The analysis showed that there was a significant reduction in muscle thickness, spasticity and reflex torque and a significant increment in motor function and dexterity in both groups after treatment ...
Dry needling plus neurorehabilitation could decrease muscle thickness, spasticity and reflex torque and improve upper-extremity motor performance and dexterity in chronic stroke patients. These change...